Bindu Chandrasekhar

406 total citations
20 papers, 348 citations indexed

About

Bindu Chandrasekhar is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bindu Chandrasekhar has authored 20 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bindu Chandrasekhar's work include Nitric Oxide and Endothelin Effects (6 papers), RNA Interference and Gene Delivery (5 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Bindu Chandrasekhar is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), RNA Interference and Gene Delivery (5 papers) and Dendrimers and Hyperbranched Polymers (4 papers). Bindu Chandrasekhar collaborates with scholars based in Kuwait, Cyprus and Qatar. Bindu Chandrasekhar's co-authors include Ibrahim F. Benter, Saghir Akhtar, Mariam H.M. Yousif, Gursev S. Dhaunsi, Mabayoje A. Oriowo, Ahmed Z. El‐Hashim, Rajiv K. Saxena, Waleed M. Renno, Islam Ullah Khan and Alexander E. Omu and has published in prestigious journals such as PLoS ONE, Diabetes and British Journal of Pharmacology.

In The Last Decade

Bindu Chandrasekhar

20 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bindu Chandrasekhar Kuwait 12 183 95 64 59 48 20 348
Chia‐Ying Lien United States 11 138 0.8× 364 3.8× 22 0.3× 24 0.4× 48 1.0× 31 483
Le-Ning Zhang China 10 84 0.5× 53 0.6× 7 0.1× 100 1.7× 132 2.8× 15 454
Heike Runge Germany 10 213 1.2× 20 0.2× 26 0.4× 13 0.2× 92 1.9× 13 417
Ingrid Fricks United States 10 286 1.6× 31 0.3× 27 0.4× 10 0.2× 74 1.5× 12 518
Giuseppina Daniela Naimo Italy 15 247 1.3× 29 0.3× 9 0.1× 32 0.5× 108 2.3× 26 566
Yasuhiro Ichikawa Japan 11 127 0.7× 76 0.8× 7 0.1× 15 0.3× 36 0.8× 38 383
R. Cheng China 8 129 0.7× 18 0.2× 35 0.5× 265 4.5× 105 2.2× 15 508
Martina Kropp Switzerland 13 196 1.1× 57 0.6× 3 0.0× 29 0.5× 91 1.9× 32 539
Lilian Puebla Spain 6 235 1.3× 42 0.4× 4 0.1× 36 0.6× 38 0.8× 19 393
Veli‐Pekka Ronkainen Finland 12 265 1.4× 140 1.5× 4 0.1× 21 0.4× 30 0.6× 26 523

Countries citing papers authored by Bindu Chandrasekhar

Since Specialization
Citations

This map shows the geographic impact of Bindu Chandrasekhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bindu Chandrasekhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bindu Chandrasekhar more than expected).

Fields of papers citing papers by Bindu Chandrasekhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bindu Chandrasekhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bindu Chandrasekhar. The network helps show where Bindu Chandrasekhar may publish in the future.

Co-authorship network of co-authors of Bindu Chandrasekhar

This figure shows the co-authorship network connecting the top 25 collaborators of Bindu Chandrasekhar. A scholar is included among the top collaborators of Bindu Chandrasekhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bindu Chandrasekhar. Bindu Chandrasekhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chandrasekhar, Bindu, et al.. (2023). Vasodilator Effect of Trace Amines, 3-Iodothyronamine, and RO5263397 in the Rat Perfused Kidney: Comparison with Tryptamine. Pharmacology. 108(4). 368–378. 1 indexed citations
2.
Mousa, Alyaa, et al.. (2022). Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats. European Journal of Pharmacology. 933. 175265–175265. 8 indexed citations
3.
Akhtar, Saghir, Bindu Chandrasekhar, & Ibrahim F. Benter. (2020). 455-P: Pan-ErbB Inhibition Attenuates Diabetes-Induced Vascular Dysfunction in an Experimental Model of Diabetes. Diabetes. 69(Supplement_1). 2 indexed citations
4.
Akhtar, Saghir, Bindu Chandrasekhar, Mariam H.M. Yousif, et al.. (2019). Chronic administration of nano-sized PAMAM dendrimers in vivo inhibits EGFR-ERK1/2-ROCK signaling pathway and attenuates diabetes-induced vascular remodeling and dysfunction. Nanomedicine Nanotechnology Biology and Medicine. 18. 78–89. 23 indexed citations
5.
Akhtar, Saghir, et al.. (2016). Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney. International Journal of Pharmaceutics. 514(2). 353–363. 14 indexed citations
6.
7.
8.
Akhtar, Saghir, et al.. (2015). Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor. PLoS ONE. 10(11). e0141657–e0141657. 26 indexed citations
9.
Akhtar, Saghir, et al.. (2015). Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo. PLoS ONE. 10(7). e0132215–e0132215. 19 indexed citations
10.
Akhtar, Saghir, et al.. (2013). On the nanotoxicity of PAMAM dendrimers: Superfect® stimulates the EGFR–ERK1/2 signal transduction pathway via an oxidative stress-dependent mechanism in HEK 293 cells. International Journal of Pharmaceutics. 448(1). 239–246. 27 indexed citations
11.
Akhtar, Saghir, et al.. (2013). Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction. PLoS ONE. 8(6). e67813–e67813. 28 indexed citations
12.
Akhtar, Saghir, Mariam H.M. Yousif, Bindu Chandrasekhar, & Ibrahim F. Benter. (2012). Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury. PLoS ONE. 7(6). e39066–e39066. 63 indexed citations
13.
Akhtar, Saghir, et al.. (2011). Angiotensin‐(1‐7) inhibits epidermal growth factor receptor transactivation via a Mas receptor‐dependent pathway. British Journal of Pharmacology. 165(5). 1390–1400. 54 indexed citations
14.
Khan, Islam Ullah, et al.. (2005). Evidence for the Presence of Beta-3-Adrenoceptors Mediating Relaxation in the Human Oviduct. Pharmacology. 74(3). 157–162. 4 indexed citations
15.
Khan, Islam Ullah, et al.. (2005). Attenuated Noradrenaline-Induced Contraction of Pulmonary Arteries from Rats Treated with Monocrotaline: Role of Rho Kinase. Journal of Vascular Research. 42(5). 433–440. 11 indexed citations
16.
Chandrasekhar, Bindu, et al.. (2004). Interaction of BKCa channel modulators with adrenergic agonists in the rat aorta is influenced by receptor reserve. Vascular Pharmacology. 41(4-5). 119–124. 4 indexed citations
17.
Oriowo, Mabayoje A., et al.. (2003). α1-adrenoceptor subtypes mediating noradrenaline-induced contraction of pulmonary artery from pulmonary hypertensive rats. European Journal of Pharmacology. 482(1-3). 255–263. 19 indexed citations
18.
Yousif, Mariam H.M., et al.. (2003). Noradrenaline-induced Vasoconstriction in the Uterine Vascular Bed of Pregnant Rats Chronically Treated with l-NAME: Role of Prostanoids. Journal of Cardiovascular Pharmacology. 42(3). 428–435. 11 indexed citations
19.
Yousif, Mariam H.M., et al.. (2002). Acetylcholine-Induced Vasodilation in the Uterine Vascular Bed of Pregnant Rats with Adriamycin-Induced Nephrosis. Medical Principles and Practice. 11(2). 57–64. 1 indexed citations
20.
Saxena, Rajiv K. & Bindu Chandrasekhar. (2000). A novel nonphagocytic mechanism of erythrocyte destruction involving direct cell-mediated cytotoxicity.. PubMed. 71(3). 227–37. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chia‐Ying Lien Breakdown of academic impact, for papers by Le-Ning Zhang Breakdown of academic impact, for papers by Heike Runge Breakdown of academic impact, for papers by Ingrid Fricks Breakdown of academic impact, for papers by Giuseppina Daniela Naimo Breakdown of academic impact, for papers by Yasuhiro Ichikawa Breakdown of academic impact, for papers by R. Cheng Breakdown of academic impact, for papers by Martina Kropp Breakdown of academic impact, for papers by Lilian Puebla Breakdown of academic impact, for papers by Veli‐Pekka Ronkainen
Rankless by CCL
2026